After quantification of SLC26A9 protein expression in the tumor and adjacent normal tissues, the patient population was sorted based on SLC26A9 expression above (SLC26A9 high) or below (SLC26A9 low) the median. The gene discussed is SLC26A9; the disease is neoplasm.